佐力药业：大健康产品目前处于研发优化与商业化布局阶段

Core Viewpoint - Zhaoli Pharmaceutical (300181) is in the research optimization and commercialization phase for its health products, with a planned official launch next year, contingent on R&D progress and sales channel development [1] Group 1 - The health products will primarily utilize internet sales and will operate separately from the existing pharmaceutical sales team [1] - The company aims to leverage its unique advantage in the exclusive raw material of Wuling mushroom powder to actively explore the market [1]